549 filings
8-K
CRVO
CervoMed Inc
14 Dec 20
Regulation FD Disclosure
11:32am
4
CRVO
CervoMed Inc
18 Nov 20
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
9:15pm
4
CRVO
CervoMed Inc
18 Nov 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
8:33am
10-Q
2020 Q3
CRVO
CervoMed Inc
Quarterly report
12 Nov 20
5:28pm
8-K
CRVO
CervoMed Inc
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm
4
q0sl 05bx5mi5ybc1g
21 Oct 20
Diffusion Pharmaceuticals / CHRISTOPHER D GALLOWAY ownership change
8:04pm
3
99v17i kpmrvsli
21 Oct 20
Diffusion Pharmaceuticals / CHRISTOPHER D GALLOWAY ownership change
7:49pm
8-K
d9eeomyl 8o
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
4
f4fx3n90xk
14 Oct 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:40pm
3
neeclyxgcipel qkf6
14 Oct 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:27pm
8-K
3ff4n8vwf
9 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
EFFECT
plg5 g7tzpeyfx2k
5 Oct 20
Notice of effectiveness
12:21am
424B2
agzw1gcs8acykek
2 Oct 20
Prospectus for primary offering
4:16pm
4
44bk84lhv88lcinx9uo
1 Oct 20
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:29pm
3
8dta3sen
1 Oct 20
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:22pm
CORRESP
ynaq5uee9fzj33 5241x
30 Sep 20
Correspondence with SEC
12:00am
UPLOAD
p8k51
29 Sep 20
Letter from SEC
12:00am
8-K
utp95 3aza
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
3005nnzm914hhlw2 129
15 Sep 20
Regulation FD Disclosure
2:50pm